The EBSP would enable Europeans to travel to the U.S. visa-free, provided that EU states grant access to biometric databases for traveler screening and IDV.
The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, ...
PROBLEM SOLVER AWARD FINALISTThe University of Queensland, Monash University and The University of SydneyACEMID: revolutionising early detection and the fight against melanoma ...
Haoyu Cheng, Ph.D., assistant professor of biomedical informatics and data science at Yale School of Medicine, has developed a new algorithm capable of building complete human genomes using standard ...
Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...
BEIJING -- Chinese scientists have launched an ambitious international megascience project to decode the genetic blueprint of major land plant lineages, aiming to construct a complete "tree of life" ...
Each year, 263 million people get malaria. But from the parasite's perspective, infecting humans is harder than you might think, and requires completing an epic journey within the tiny body of a ...
First came AlphaFold. Now comes AlphaGenome for DNA. When scientists first sequenced the human genome in 2003, they revealed the full set of DNA instructions that make a person. But we still didn’t ...
Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results